Physician profile
Sarah Dalhoumi
NPI 1033435383
$3,151.60
in general payments reported to CMS, 2019-2025
19 companies · $691 in 2025
The $691 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2021: $35.95 · 2022: $730 · 2023: $487 · 2024: $779 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,956.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,361.79 | 2023-2025 | Botox |
| Allergan, INC. | $735.22 | 2019-2022 | |
| Astellas Pharma US INC | $369.96 | 2023-2025 | Veozah |
| Ibsa Pharma INC. | $125.00 | 2023 | Tirosint |
| Duchesnay USA Incorporated | $116.59 | 2019 | |
| Amgen INC. | $75.45 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $62.03 | 2019-2023 | Evkeeza |
| Purelife, LLC | $60.00 | 2019 | |
| Novo Nordisk INC | $40.26 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $30.57 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $26.86 | 2025 | |
| Amryt Pharma Holdings LTD | $26.07 | 2022 | |
| Amarin Pharma, INC. | $20.12 | 2022 | |
| Aegerion Pharmaceuticals, INC. | $19.97 | 2019 | |
| Irhythm Technologies, INC. | $19.17 | 2023 | Zio Xt Patch |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $17.98 | 2022 | |
| Millicent US INC | $16.14 | 2025 | Femring, Intrarosa |
| Acella Pharmaceuticals, LLC | $14.79 | 2024 | NP Thyroid 60 |
| Ascend Therapeutics US, LLC | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Dalhoumi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.